How Premium Video Drives Sales in the Pharmaceutical Category
Insights: Impact In Action

How Premium Video Drives Sales in the Pharmaceutical Category

Discover how TV campaigns move audiences, from awareness to action, in our new TV Means Business attribution series.

TV drives discovery, education and sales results for brands

Welcome to the first release in our new category attribution series, exploring the impact premium video campaigns have on a brand’s sales.

In this pharma-focused report, we analyzed 17 prescription remedy brands including: Skyrizi, Rinvoq, Otezla, Wegovy, Tremfya, Vraylar, Sotyktu, Ozempic, Breztri, Arexvy, Camzyos, Eylea, Caplya, Ingrezza, Dupizent, Keytruda and Botox to quantify the real impact that TV has on sales.

What's inside the report?

  • Key stats and trends on the pharmaceutical industry
  • A breakdown of our analysis methodology
  • Mid-funnel results: search and website traffic uplifts driven by TV
  • Analysis of sales lift across leading pharma brands

Why Download?

See how multiscreen TV advertising delivers measurable sales impact while helping patients of all ages educate themselves and take action.

What is CTV? - Report Preview

Get Immediate Access To Our Content

You have questions. We have answers.

Get immediate access to our Insights library.